275 related articles for article (PubMed ID: 17760968)
1. Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc: an in situ zymographic and gene therapy study.
Le Maitre CL; Hoyland JA; Freemont AJ
Arthritis Res Ther; 2007; 9(4):R83. PubMed ID: 17760968
[TBL] [Abstract][Full Text] [Related]
2. A preliminary in vitro study into the use of IL-1Ra gene therapy for the inhibition of intervertebral disc degeneration.
Le Maitre CL; Freemont AJ; Hoyland JA
Int J Exp Pathol; 2006 Feb; 87(1):17-28. PubMed ID: 16436110
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc.
Hoyland JA; Le Maitre C; Freemont AJ
Rheumatology (Oxford); 2008 Jun; 47(6):809-14. PubMed ID: 18397957
[TBL] [Abstract][Full Text] [Related]
4. Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1beta and TNFalpha expression profile.
Le Maitre CL; Hoyland JA; Freemont AJ
Arthritis Res Ther; 2007; 9(4):R77. PubMed ID: 17688691
[TBL] [Abstract][Full Text] [Related]
5. The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration.
Le Maitre CL; Freemont AJ; Hoyland JA
Arthritis Res Ther; 2005; 7(4):R732-45. PubMed ID: 15987475
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 receptor antagonist deficient mice provide insights into pathogenesis of human intervertebral disc degeneration.
Phillips KL; Jordan-Mahy N; Nicklin MJ; Le Maitre CL
Ann Rheum Dis; 2013 Nov; 72(11):1860-7. PubMed ID: 23396662
[TBL] [Abstract][Full Text] [Related]
7. Expression of proteinase-activated receptor-2 in the intervertebral disc.
Iida R; Akeda K; Kasai Y; Masuda K; Morimoto R; Sakakibara T; Sato M; Uchida A
Spine (Phila Pa 1976); 2009 Mar; 34(5):470-8. PubMed ID: 19247167
[TBL] [Abstract][Full Text] [Related]
8. Cytokine Inhibitors Upregulate Extracellular Matrix Anabolism of Human Intervertebral Discs under Alginate Beads and Alginate-Embedded Explant Cultures.
Kakutani K; Yurube T; An HS; Doita M; Masuda K
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569715
[TBL] [Abstract][Full Text] [Related]
9. Expression of cartilage-derived morphogenetic protein in human intervertebral discs and its effect on matrix synthesis in degenerate human nucleus pulposus cells.
Le Maitre CL; Freemont AJ; Hoyland JA
Arthritis Res Ther; 2009; 11(5):R137. PubMed ID: 19754961
[TBL] [Abstract][Full Text] [Related]
10. IL-20 may contribute to the pathogenesis of human intervertebral disc herniation.
Huang KY; Lin RM; Chen WY; Lee CL; Yan JJ; Chang MS
Spine (Phila Pa 1976); 2008 Sep; 33(19):2034-40. PubMed ID: 18758357
[TBL] [Abstract][Full Text] [Related]
11. Accelerated cellular senescence in degenerate intervertebral discs: a possible role in the pathogenesis of intervertebral disc degeneration.
Le Maitre CL; Freemont AJ; Hoyland JA
Arthritis Res Ther; 2007; 9(3):R45. PubMed ID: 17498290
[TBL] [Abstract][Full Text] [Related]
12. 2002 SSE Award Competition in Basic Science: expression of major matrix metalloproteinases is associated with intervertebral disc degradation and resorption.
Weiler C; Nerlich AG; Zipperer J; Bachmeier BE; Boos N
Eur Spine J; 2002 Aug; 11(4):308-20. PubMed ID: 12193991
[TBL] [Abstract][Full Text] [Related]
13. Effects of interleukin-17A in nucleus pulposus cells and its small-molecule inhibitors for intervertebral disc disease.
Suyama K; Sakai D; Hirayama N; Nakamura Y; Matsushita E; Terayama H; Qu N; Tanaka O; Sakabe K; Watanabe M
J Cell Mol Med; 2018 Nov; 22(11):5539-5551. PubMed ID: 30207057
[TBL] [Abstract][Full Text] [Related]
14. Genetic and functional studies of the intervertebral disc: a novel murine intervertebral disc model.
Pelle DW; Peacock JD; Schmidt CL; Kampfschulte K; Scholten DJ; Russo SS; Easton KJ; Steensma MR
PLoS One; 2014; 9(12):e112454. PubMed ID: 25474689
[TBL] [Abstract][Full Text] [Related]
15. Expression and regulation of neurotrophins in the nondegenerate and degenerate human intervertebral disc.
Purmessur D; Freemont AJ; Hoyland JA
Arthritis Res Ther; 2008; 10(4):R99. PubMed ID: 18727839
[TBL] [Abstract][Full Text] [Related]
16. Matrix synthesis and degradation in human intervertebral disc degeneration.
Le Maitre CL; Pockert A; Buttle DJ; Freemont AJ; Hoyland JA
Biochem Soc Trans; 2007 Aug; 35(Pt 4):652-5. PubMed ID: 17635113
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases and aggrecanase: their role in disorders of the human intervertebral disc.
Roberts S; Caterson B; Menage J; Evans EH; Jaffray DC; Eisenstein SM
Spine (Phila Pa 1976); 2000 Dec; 25(23):3005-13. PubMed ID: 11145811
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of matrix metalloproteinase-10, nerve growth factor and substance P in the painful degenerate intervertebral disc.
Richardson SM; Doyle P; Minogue BM; Gnanalingham K; Hoyland JA
Arthritis Res Ther; 2009; 11(4):R126. PubMed ID: 19695094
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory profiles in canine intervertebral disc degeneration.
Willems N; Tellegen AR; Bergknut N; Creemers LB; Wolfswinkel J; Freudigmann C; Benz K; Grinwis GC; Tryfonidou MA; Meij BP
BMC Vet Res; 2016 Jan; 12():10. PubMed ID: 26757881
[TBL] [Abstract][Full Text] [Related]
20. IL-1Ra deficiency accelerates intervertebral disc degeneration in C57BL6J mice.
Swamy G; Salo P; Duncan N; Jirik F; Matyas J
JOR Spine; 2022 Jun; 5(2):e1201. PubMed ID: 35783913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
